Drug evolution concept in drug design: 2. Chimera method

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.2174/157340606776056214
AuthorSearch for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1; Search for: 1
Affiliation
  1. National Research Council of Canada. NRC Biotechnology Research Institute
FormatText, Article
SubjectChimera method; drug design; drug library; pharmaceutical; scaffold; para-aminobenzoic acid; building blocks; drug evolution; 4-aminobenzoic acid; binding sites; chemistry, pharmaceutical; chimera; combinatorial chemistry techniques; drug design; drug evaluation, preclinical; salicylic acid; structure-activity relationship
Abstract
Publication date
PublisherBentham Science Publishers
In
LanguageEnglish
Peer reviewedYes
Identifier20852708
NRC numberNRC-BRI-47487
NPARC number3539192
Export citationExport as RIS
Report a correctionReport a correction (opens in a new tab)
Record identifiera3cdce56-7c86-4938-9fb3-a47d028f93a0
Record created2009-03-01
Record modified2020-04-22
Date modified: